Quick Takeaways
- Charles Cherington filed SCHEDULE 13D/A for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA).
- Disclosed ownership: 35%.
- Date of event: 10 Feb 2026.
Charles Cherington - 10 Feb 2026 SCHEDULE 13D/A Report for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA)
- Filing Manager
- Charles Cherington
- Reporting Manager
- Charles Cherington
- Symbol
- ERNA
- Shares outstanding
- 31,098,948 shares
- Disclosed Ownership
- 10,791,335 shares
- Ownership
- 35%
- Form type
- SCHEDULE 13D/A
- Filing time
- 17 Feb 2026, 21:26:03 UTC
- Date of event
- 10 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Charles Cherington disclosed 35% ownership in Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA) on 10 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 21:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Charles Cherington | 35% | 10,791,335 | 10,791,335 | /s/ Charles Cherington | Charles Cherington | 0001448698 |